Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution.

Autores de IIS La Fe

• Miguel Ángel Sanz Alonso

  Autor

• 

  Javier De La Rubia Comos

  Autor

• Guillermo Sanz Santillana

  Autor

• Guillermo Martin Aragones

  Autor

• Jesus Antonio Martinez Dominguez

  Autor

• Isidro Jarque Ramos

  Autor

• Amparo Sempere Talens

  Autor

• Federico Gomis Bernal

  Autor

• María Leonor Senent Peris

  Autor

Participantes ajenos a IIS La Fe

• Soler MA

Abstract

To determine if peripheral-blood stem cells (PBSC) collected during the recovery of standard induction and consolidation chemotherapy in acute myeloblastic leukemia (AML) can be used as a safe tool for autologous transplantation, and to study aspects of the autologous blood stem-cell transplantation (ABSCT) procedure and their results in AML patients in first remission.